There have been no satisfactory therapies on stabilizing and repairing ruptured plagues nowadays, which are the fundamental causes of acute coronary syndrome (ACS) and stroke. The aim of this study was to investigate the therapeutic potential of bone marrow mesenchymal stem cells (MSCs) in stabilizing and repairing ruptured plaques.
Materials and Methods
28 male New Zealand rabbits were randomly divided into 2 groups after establishment of atherosclerotic disrupted plaque model by liquid nitrogen frostbite: MSCs transplantation group and control group. MSCs were isolated, cultured in vitro, and labeled with BrdU. BrdU-incorporated MSCs (MSCs transplantation group) or an equal amount of IMDM medium without MSCs (control group) were transplanted into vessels with ruptured plaque. PAI-1, MMP-9 and hs-CRP were determined by ELISA of blood 3 days and 4 weeks after transplantation. Rabbits were sacrificed 4 weeks after transplantation and plaque repair was assessed by HE and Masson's trichrome staining. Transplanted BrdU-positive cells were identified by immunohistochemistry.
Four weeks after MSCs transplantation, PAI-1, MMP-9 and hs-CRP were reduced significantly in all experimental animals (p < 0.001). The reduction was more evident in the transplantation group than in the control group (p < 0.01). In addition, the transplantation group showed dramatically higher numbers of newly formed endothelial cells, collagen fibers, and proliferative BrdU-positive cells at plaque areas.
This study demonstrates that allogeneic MSCs transplantation can stabilize and repair ruptured plaques, which represents a novel approach for ACS and stroke.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Thrombosis Research
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: detection of vulnerable patients by angioscopy.J Am Coll Cardiol. 2006; 47: 2194-2200
- Atherosclerotic plaque vulnerability as an explanation for the increased risk of stroke in elderly undergoing carotid artery stenting.Stroke. 2011; 42: 2550-2555
- A new heart: somatic stem cells and myocardial regeneration.J Surg Oncol. 2012; 105: 475-480
- Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects.Ann Thorac Surg. 2002; 73: 1919-1925
- Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation.J Thorac Cardiovasc Surg. 2002; 123: 1132-1140
- The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness.Cytotherapy. 2012; 14: 670-678
- Developing a novel rabbit model of atherosclerotic plaque rupture and thrombosis by cold-induced endothelial injury.. 2009; 16: 39https://doi.org/10.1186/1423-0127-16-39
- Multilineage potential of adult human mesenchymal stem cells.Science. 1999; 284: 143-147
- Thrombosis and Acute coronary syndrome.Thromb Res. 2012; 129: 235-240
- Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome.Circ J. 2012; 76: 778-783
- Biomarkers of chronic inflammatory state in uremia and cardiovascular disease.Int J Inflamm. 2012; 2012: 360147
- Harmful immune reactions during acute myocardial infarction.Med Hypotheses. 2012; 78: 703-706
- Plasma concentration of C- reactive protein and the calculated Framingham coronary heart disease risk score.Circulation. 2003; 108: 161-165
- C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes.Int J Cardiol. 2011; 152: 7-12
- Effects of standard treatment on the dynamics of matrix metalloproteinases gene expression in patients with acute coronary syndromes.Pharmacol Rep. 2010; 62: 1108-1116
- Levels of haemostatic factors, atherosclerosis and cardiovascular disease.Vascul Pharmacol. 2002; 39: 109-112
- Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction.Inflammation. 2007; 30: 97-104
- Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury.Circ Res. 2003; 93: e17-e24
- Pluripotency of mesenchymal stem cells derived from adult marrow.Nature. 2002; 418: 41-49
- Immunogenicity of allogeneic mesenchymal stem cells. Immunogenicity of allogeneic mesenchymal stem cells.J Cell Mol Med. 2011; https://doi.org/10.1111/j.1582-4934
- The immunomodulatory capacity of mesenchymal stem cells.Trends Mol Med. 2012; 18: 128-134
- Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.Transplantation. 2003; 75: 389-397
Published online: April 25, 2013
Accepted: April 1, 2013
Received in revised form: February 25, 2013
Received: October 15, 2012
© 2013 Elsevier Ltd. Published by Elsevier Inc. All rights reserved.